Cosmica Biosciences is a biotechnology startup that is focused on enhancing human resilience for longevity & deep space exploration. Leveraging the potential of space biology, the company is dedicated to developing treatments for age-related diseases. Founded in 2023 and based in the United States, Cosmica Biosciences has recently secured Pre Seed Round investment on 26 June 2023 from LongevityTech.fund. The company's mission and innovative approach to addressing healthcare challenges make it an intriguing prospect for potential venture capital investors, particularly in the rapidly evolving biotechnology sector.
No recent news or press coverage available for Cosmica Biosciences.